INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

6,850 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
48
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$1.14M
3,240 sh
Nov 12, 2025Nov 14, 2025
Page 165 of 172
← PrevNext →
traded Nov 12, 2025
+2d
SEC Form 4

Evidence

45
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$1.61M
4,240 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.16M
12.7K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

44
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.37M
26.4K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

42
BW
Betz WilliamEVP & CFO
NXPINXP Semiconductors N.V.
Open-market sale
SELL$1.47M
7,299 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

42
SG
Sentient Executive Gp Iii, Ltd10% Owner
GROBrazil Potash Corp.
Open-market sale
SELL$7.73M
3.86M sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

42
CJ
Chakma JustinChief Business Officer
SPRYARS Pharmaceuticals, Inc.
Open-market sale
SELL$1.21M
136.4K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

42
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$674K
1,769 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

41
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$278K
789 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

41
SB
Szady Annette BrookensDirector
DGICADONEGAL GROUP INC
Open-market sale
SELL$89K
4,500 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

40
PR
Pelizzon David RDirector, 10% Owner
ATECAlphatec Holdings, Inc.
Open-market sale
SELL$5.20M
250.0K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

40
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$5.19M
59.1K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

40
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.78M
31.4K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

40
SC
Squadron Capital LLC10% Owner
ATECAlphatec Holdings, Inc.
Open-market sale
SELL$5.20M
250.0K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

40
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$5.00M
57.5K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

40
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$7.36M
85.7K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

39
LM
Lo Steve MingChief Accounting Officer
REALTheRealReal, Inc.
Open-market sale
SELL$193K
13.5K sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

39
GC
Gassert ChadSVP - CORP. DEV. & STRATEGY
ANIPANI PHARMACEUTICALS INC
Open-market sale
SELL$1.30M
14.6K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

38
HJ
Hecker Rick JosephSVP & GENERAL COUNSEL
DGICADONEGAL GROUP INC
Open-market sale
SELL$18K
900 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

38
CF
Cash Paul FGeneral Counsel & Corp. Secy.
WHWYNDHAM HOTELS & RESORTS, INC.
Open-market sale
SELL$2.61M
36.4K sh
Nov 14, 2025Nov 14, 2025
traded Nov 14, 2025
+0dSEC Form 4

Evidence

38
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
700 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

37
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$699K
7,710 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

37
BJ
Battershell Carol JaneDirector
GEVOGevo, Inc.
Open-market sale
SELL$153K
75.6K sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

36
EI
Eskenazi IleneDirector
AKAA.K.A. BRANDS HOLDING CORP.
Open-market sale
SELL$157K
12.2K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

34
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$56K
154 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

34
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$89K
251 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

34
LG
Lepore Dawn GDirector
LDIloanDepot, Inc.
Open-market sale
SELL$89K
30.6K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

34
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$175K
500 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

33
BJ
Baack Jerry J.Director, CEO
BWBBridgewater Bancshares Inc
Open-market sale
SELL$307K
18.0K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

32
Armstrong BrianDirector, Chairman and CEO, 10% Owner
COINCoinbase Global, Inc.
Open-market sale · 10b5-1 plan
SELL$2.95M
9,196 sh
Nov 10, 2025Nov 14, 2025
traded Nov 10, 2025
+4dSEC Form 4

Evidence

32
DB
Dageville BenoitDirector, Founder and Chief Architect
SNOWSnowflake Inc.
Open-market sale · 10b5-1 plan
SELL$6.61M
25.0K sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

31
CJ
Chakma JustinChief Business Officer
SPRYARS Pharmaceuticals, Inc.
Open-market sale
SELL$267K
30.0K sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

31
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$36K
100 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

31
WX
Wu XiaobinPresident and COO
ONCBeOne Medicines Ltd.
Open-market sale
SELL$43K
120 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

30
BJ
Baack Jerry J.Director, CEO
BWBBridgewater Bancshares Inc
Open-market sale
SELL$119K
6,993 sh
Nov 13, 2025Nov 14, 2025
traded Nov 13, 2025
+1dSEC Form 4

Evidence

30
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$116K
332 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

30
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$232K
664 sh
Nov 12, 2025Nov 14, 2025
traded Nov 12, 2025
+2dSEC Form 4

Evidence

57
LS
Levy Adam ScottCFO and Secretary
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$1.53M
32.7K sh
Nov 11, 2025Nov 13, 2025
traded Nov 11, 2025
+2dSEC Form 4

Evidence

54
KD
Karydas DaphneDirector
MLYSMineralys Therapeutics, Inc.
Open-market sale
SELL$463K
10.1K sh
Nov 13, 2025Nov 13, 2025
traded Nov 13, 2025
+0dSEC Form 4

Evidence

54
VE
Vivas EduardoDirector
APPAppLovin Corp
Open-market sale
SELL$11.38M
17.5K sh
Nov 10, 2025Nov 13, 2025
traded Nov 10, 2025
+3dSEC Form 4

Evidence